Pharma		31.63%
Services		25.63%
Medtech		14.36%
Diagnostics		11.16%
Biotech		3.52%
Generics		3.30%

Europe		54.35%
EM Asia		9.92%
Nordamerika		7.61%
Asien		6.99%
EM Europe		5.70%
EM Rest World		5.00%